+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recent progress in gastrointestinal stromal tumor (GIST)



Recent progress in gastrointestinal stromal tumor (GIST)



Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(9): 1495-1501



Gastrointestinal stromal tumor (GIST) is a quite common gastrointestinal mesenchymal tumor entity that has been recently established by pathologists. The prediction of the biologic behavior of GISTs is relatively difficult. Recently, classifications of the biologic behavior of GISTs according to metastatic potential (low risk, intermediate, high risk) have been proposed. The gain-of function mutation of c-kit proto-oncogene has been detected in GISTs and its role in molecular pathogenesis of GIST has been established. Imatinib mesylate (formerly STI 571, Glivec, Novartis Pharmaceuticals Corp, Switzerland) inhibits the tyrosin-kinase activity of KIT receptor, and clinical trials for GIST are in progress. In the past, no effective drug was known for the treatment of GISTs. Recently, the effectiveness of Imatinib mesylate in patients bearing metastatic GISTs has been reported. The treatment and prognosis of GIST will change significantly in the coming few years, as the clinical application of Imatinib mesylate becomes more common. In the near future, the value of Imatinib mesylate as a post-operative adjuvant chemotherapy for patients with GISTs without metastasis should be studied, and the way to classify GISTs according to biologic behavior will become quite important.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047186502

Download citation: RISBibTeXText

PMID: 12355934


Related references

Clinical pathology of gastrointestinal stromal tumor (GIST): With special reference to change of the cencept of gastrointestinal mesenchymal tumor (GIMT) and the definition and organ specificity of GIST. Stomach and Intestine (Tokyo) 36(9): 1113-1127, 2001

Is gastrointestinal stromal tumor (GIST) originating from the rectovaginal septum GIST or extra-GIST (EGIST)? A case report with literature review. European Journal of Gynaecological Oncology 36(6): 750-754, 2016

Recent advances and novel agents forgastrointestinal stromal tumor GIST. 2012

Recent advances and novel agents for gastrointestinal stromal tumor GIST. Journal of Hematology & Oncology 5(1): 21, 2012

Recent advances and novel agents for gastrointestinal stromal tumor (GIST). Journal of Hematology & Oncology 5: 21-21, 2012

Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST). Cancer Biology and Therapy 3(3): 251-258, 2004

Gastrointestinal stromal tumor (GIST) pathogenesis, familial GIST, and animal models. Seminars in Diagnostic Pathology 23(2): 63-69, 2006

When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis. World Journal of Surgical Oncology 7: 8, 2009

Coexistence of gastrointestinal stromal tumor (GIST) of the rectum and adenocarcinoma of the prostate in a patient with familial GIST. Onkologie 31(12): 697-699, 2008

Antitumor effect of the tyrosine kinase inhibitor nilotinib on gastrointestinal stromal tumor (GIST) and imatinib-resistant GIST cells. Plos One 9(9): E107613, 2015

Clinical pathology of gastrointestinal stromal tumor With special reference to change of the cencept of gastrointestinal mesenchymal tumor and the definition and organ specificity of GIST. Stomach & Intestine (Tokyo) 36(9): 1113-1127, August, 2001

Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: a subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene. Human Pathology 35(10): 1223-1230, 2004

Impact of the Japanese gastric cancer screening system on treatment outcomes in gastric gastrointestinal stromal tumor (GIST): an analysis based on the GIST registry. Annals of Surgical Oncology 22(1): 232-239, 2015

Infrequent Tumors of the Gastrointestinal Tract Including Gastrointestinal Stromal Tumor (GIST). Pet Clinics 3(2): 207-215, 2008

Recurrent lower gastrointestinal bleeding due to a gastrointestinal stromal tumor (GIST) of the small intestine. Polski Merkuriusz Lekarski 20(118): 440-441, 2006